Pfizer’s RSV vaccine for older adults, pregnant people approved by Health Canada – GLOBAL

January 4, 2024

Health Canada on Thursday approved another respiratory syncytial virus (RSV) vaccine for adults over the age of 60 and pregnant people.

Pfizer’s bivalent RSV vaccine, Abrysvo, has been authorized for the use of pregnant individuals from 32 through 36 weeks gestational age for the prevention of lower respiratory tract disease caused by RSV in infants from birth through six months of age, according to Health Canada.

The shot is also approved for Canadians 60 years and older.

“Vaccines are considered to be the most effective tool in public health for preventing illness and can help reduce the stress on our healthcare system and professionals including nurses, doctors, and others on the frontline,” Dr. Darine El-Chaâr, maternal-fetal medicine physician at The Ottawa Hospital, said in a press release on Thursday.

Read more: https://globalnews.ca/news/10203419/pfizer-rsv-vaccine-pregnant-people-health-canada/